Project Description

Invited Expert Interview
Interview with: Miren Taberna MD PhD
Interview date: June 1, 2020
Disclosures: Consulting/Advisory Role: Nanobiotix, Merck; Speakers Bureau: Merck, AstraZeneca Spain, Bristol-Myers Squibb, MSD Oncology
Affiliations: Medical Oncologist, Researcher, Head and Neck Cancer Unit; Catalan Institute of Oncology (ICO), Barcelona
Subtitles/Captions:

Disclaimer: Springer Healthcare selected the experts for interview. The expert interviews appearing herein were not prepared or reviewed by ASCO and have not been subject to a peer review process. The ideas and opinions expressed herein do not necessarily reflect those of ASCO. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. Full disclaimer.

© 2020 American Society of Clinical Oncology (ASCO®). All Rights Reserved.

Subtitles:
Loading...
Invited Expert Interview
Interview with: Miren Taberna MD PhD
Interview date: June 1, 2020
Disclosures: Consulting/Advisory Role: Nanobiotix, Merck; Speakers Bureau: Merck, AstraZeneca Spain, Bristol-Myers Squibb, MSD Oncology
Affiliations: Medical Oncologist, Researcher, Head and Neck Cancer Unit; Catalan Institute of Oncology (ICO), Barcelona
Subtitles/Captions:

Disclaimer: Springer Healthcare selected the experts for interview. The expert interviews appearing herein were not prepared or reviewed by ASCO and have not been subject to a peer review process. The ideas and opinions expressed herein do not necessarily reflect those of ASCO. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this publication or to any errors or omissions. Full disclaimer.

© 2020 American Society of Clinical Oncology (ASCO®). All Rights Reserved.